Cytokinetics Inc (CYTK)

Exchange
NASDAQ
Symbol
CYTK
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    53.99
  • High
    55.69
  • Low
    53.19
  • Close
    55.50
  • Volume
    2,316,110

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
5.87
Payables turnover
8.07
Working capital turnover
0.01
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
62.19
Number of days of payables
45.22
Fixed asset turnover
0.11
Total asset turnover
0.01
 Liquidity ratios
Current ratio
6.12
Quick ratio
6.40
Cash ratio
6.38
Cash conversion cycle
16.97
 Solvency ratios
Debt-to-assets ratio
0.07
Debt-to-capital ratio
—
Debt-to-equity ratio
—
Financial leverage ratio
—
Interest coverage
-17.53
 Profitability ratios
Gross profit margin
-2,581.51%
Operating profit margin
-6,589.71%
Pretax margin
-6,988.63%
Net profit margin
-6,989.27%
Operating return on assets (Operating ROA)
-60.20%
Return on assets (ROA)
-63.85%
Return on total capital
—
Return on equity (ROE)
—